Abstract
SUMMARY: We performed a retrospective review in both comprehensive stroke units of a region affected early by the coronavirus disease 2019 (COVID-19) pandemic, between March 1 and April 26, 2020, including patients with COVID-19 who underwent mechanical thrombectomy for ischemic stroke. We identified 13 cases, representing 38.2% of 34 thrombectomies performed during this period. We observed increased mortality and a high incidence of thrombotic complications during hospitalization. Given the high rate of infected patients, systematic use of full personal protection measures seems justified.
ABBREVIATIONS:
- COVID-19
- coronavirus disease 2019
- SARS-CoV-2
- Severe Acute Respiratory Syndrome coronavirus 2
Footnotes
Disclosures: Julien Pottecher—UNRELATED: Consultancy: LFB BIOMEDICAMENTS; Payment for Development of Educational Presentations: Baxter. Thiên-Nga Chamaraux-Tran—UNRELATED: Grants/Grants Pending: Société Française d’Anesthésie de et Réanimation, Comments: research grant; Payment for Lectures Including Service on Speakers Bureaus: Merck Sharp & Dohme, LFB. Francois Sellal—UNRELATED: Payment for Lectures Including Service on Speakers Bureaus: Novartis Pharmaceuticals, Sanofi, Crédit Mutuel.
- © 2020 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org
Jump to section
Related Articles
Cited By...
- Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis
- Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry
- Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases